Huabao Co reported Q3 revenue of 421 mln yuan, up 8.01% YoY, and Q3 net profit of 74.40 mln yuan, up 16.96% YoY. For the first three quarters of 2026, revenue was 1.15 bln yuan, up 15.49% YoY, and net profit was 184 mln yuan, up 139.45% YoY.

Yifan Pharmaceutical said its Singapore-registered wholly owned subsidiary SciGen Pte. Ltd. has won procurement from Singapore public hospitals and healthcare groups for concentrated norepinephrine bitartrate injection. The drug, an emergency treatment for severe acute hypotension in adults, is manufactured by its domestic unit Hefei Yifan Biopharmaceutical Co.; the production line holds PIC/S GMP certification.

Meta Platforms(META.O)：普通股发行规模从先前宣布的225亿美元上调至250亿美元。